CVE:ADK DIAGNOS - ADK Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.35 +0.01 (+1.45%) (As of 03/30/2023 05:12 PM ET) Add Compare Share Share Today's RangeC$0.34▼C$0.3550-Day RangeC$0.32▼C$0.4352-Week RangeC$0.13▼C$0.44Volume65,000 shsAverage Volume105,591 shsMarket CapitalizationC$24.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesHeadlines About DIAGNOS (CVE:ADK) StockDIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.Read More Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address ADK Stock News HeadlinesFebruary 28, 2023 | finance.yahoo.comDIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of ContextsDecember 15, 2022 | finance.yahoo.comDIAGNOS Provides Additional Information to the Closing of Private PlacementMarch 30, 2023 | WealthPop (Ad)Here’s Your Own Billion-Dollar Trading Edge (Just $0.76 a Week)2023 is a classic “stock picker’s market.” The only way to beat these markets is to pick the right stocks at the right time. Legendary trader Adam Mesh is ready to hand you his best stock pick every week… It’s the same kind of research Wall Street’s top traders use to beat the markets. Click here to get his three top picks for right now to help get you started now. November 6, 2022 | reuters.comADK.V - Diagnos Inc | Stock Price & Latest News | ReutersOctober 27, 2022 | finance.yahoo.comDIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis TechnologyAugust 18, 2022 | finance.yahoo.comDIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection SystemsJuly 27, 2022 | finance.yahoo.comDIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician OphthalmicsJune 7, 2022 | finance.yahoo.comDIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual GroupMarch 30, 2023 | WealthPop (Ad)Here’s Your Own Billion-Dollar Trading Edge (Just $0.76 a Week)2023 is a classic “stock picker’s market.” The only way to beat these markets is to pick the right stocks at the right time. Legendary trader Adam Mesh is ready to hand you his best stock pick every week… It’s the same kind of research Wall Street’s top traders use to beat the markets. Click here to get his three top picks for right now to help get you started now. February 10, 2022 | finance.yahoo.comDIAGNOS Successfully Completes ISO / MDSAP AuditOctober 28, 2021 | nz.finance.yahoo.comDIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMAAugust 17, 2021 | ca.finance.yahoo.comDIAGNOS Announces Date of Annual General and Special Meeting of ShareholdersJuly 20, 2021 | finance.yahoo.comDIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKEMarch 4, 2021 | finance.yahoo.comDIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technologyMarch 3, 2021 | finance.yahoo.comDIAGNOS Announces Stock Options GrantsFebruary 26, 2021 | markets.businessinsider.comDIAGNOS Announces Exercise of Stock Warrants and Provides a Cash UpdateFebruary 4, 2021 | marketwatch.comDIAGNOS Announces Further Deployment of its AI based CARA Technology in Saudi ArabiaSeptember 15, 2020 | finance.yahoo.comDIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in CaliforniaJuly 20, 2020 | www.bloomberg.comDIAGNOS Closes Second and Final Tranche of Private PlacementJuly 14, 2020 | finance.yahoo.comDIAGNOS Announces Signing of Service Agreement with the Colombian Telemedicine CentreJuly 7, 2020 | www.baystreet.caHealth-Care Stocks on the MarchJune 12, 2020 | www.barrons.comDiagnos Inc.April 27, 2020 | finance.yahoo.comDIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis ProgramApril 18, 2020 | www.bloomberg.comDIAGNOS Inc/CanadaMarch 27, 2020 | www.globenewswire.comDIAGNOS Announces Stock Options GrantMarch 26, 2020 | www.globenewswire.comDIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the “US White ...March 9, 2020 | www.globenewswire.comDIAGNOS Announces Closing of Oversubscribed $2.1 Million Private PlacementSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address ADK Company Calendar Last Earnings1/25/2023Today3/30/2023Next Earnings (Estimated)7/12/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE Industry Health Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolCVE:ADK CUSIPN/A CIKN/A Webwww.diagnos.ca Phone+1-450-6788882FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,480,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-121.31% Debt Debt-to-Equity Ratio245.28 Current Ratio1.42 Quick Ratio0.68 Sales & Book Value Annual SalesC$577,486.00 Price / Sales40.90 Cash FlowC$0.01 per share Price / Cash Flow60.00 Book ValueC($0.02) per share Price / Book-17.00Miscellaneous Outstanding Shares69,470,000Free FloatN/AMarket CapC$23.62 million OptionableNot Optionable Beta-0.08 Key ExecutivesMr. Andre LarenteCEO, Pres & Exec. DirectorMr. Marc-André MassueVP of Fin., CFO & Sec.Mr. Guillermo Moreno RoblesVP of SalesMr. Martin BelandDirector of MarketingKey CompetitorsCirca EnterprisesCVE:CTOAccelewareCVE:AXECounterPathTSE:PATHSiyata MobileCVE:SIMBreaking DataCVE:BKDView All CompetitorsInsidersMarc-André MassueSold 1,000 sharesTotal: C$270.00 ($0.27/share)Marc-André MassueSold 1,000 sharesTotal: C$195.00 ($0.20/share)View All Insider Transactions ADK Stock - Frequently Asked Questions How have ADK shares performed in 2023? DIAGNOS's stock was trading at C$0.28 on January 1st, 2023. Since then, ADK stock has increased by 21.4% and is now trading at C$0.34. View the best growth stocks for 2023 here. When is DIAGNOS's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 12th 2023. View our ADK earnings forecast. How were DIAGNOS's earnings last quarter? DIAGNOS Inc. (CVE:ADK) issued its quarterly earnings data on Wednesday, January, 25th. The company reported ($0.01) EPS for the quarter. The company earned $0.12 million during the quarter, compared to analysts' expectations of $0.10 million. What other stocks do shareholders of DIAGNOS own? Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN). What is DIAGNOS's stock symbol? DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK." How do I buy shares of DIAGNOS? Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is DIAGNOS's stock price today? One share of ADK stock can currently be purchased for approximately C$0.34. How much money does DIAGNOS make? DIAGNOS (CVE:ADK) has a market capitalization of C$23.62 million and generates C$577,486.00 in revenue each year. The company earns C$-2,480,000.00 in net income (profit) each year or C($0.04) on an earnings per share basis. How can I contact DIAGNOS? DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The official website for the company is www.diagnos.ca. The company can be reached via phone at +1-450-6788882. This page (CVE:ADK) was last updated on 3/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.